NSE adds 8 securities to ESM Stage I and moves 1 security (INSPIRE) from Stage I to Stage II, effective May 07-08, 2026. Affected securities will attract 100% margin and shift to Trade-for-Trade settlement.
Impact
High
Severity
High
Justification
Directly impacts trading in 9 securities with restrictive measures including 100% margin requirements and compulsory shift to Trade-for-Trade settlement, significantly affecting liquidity and trading strategies for these stocks.
NSE Surveillance circular updating the list of symbols subject to the Reversal Trade Cancellation Mechanism (RTCM) for May 2026, covering series EQ, BE, BZ, SM, ST & SZ across approximately 175 designated securities.
Impact
Medium
Severity
Medium
Justification
Routine monthly update to the RTCM symbol list for May 2026 affecting ~175 smaller/mid-cap securities; important for trading members handling these stocks but limited broader market impact since Nifty 500 and NSE Clearing-approved securities are excluded.
NSE announces the list of securities subject to the Reversal Trade Cancellation Mechanism (RTCM) for April 2026, covering 300+ stocks under enhanced surveillance.
Impact
High
Severity
High
Justification
RTCM is an NSE surveillance measure that directly cancels reversal trades in listed securities. Inclusion in this list significantly restricts trading patterns for 300+ stocks in the cash market segment for April 2026, with immediate and direct impact on trading activity and liquidity for affected securities.
NSE releases the updated list of 300+ securities subject to the Reversal Trade Cancellation Mechanism (RTCM) for March 2026, a surveillance measure to cancel trades that are reversed within a short timeframe.
Impact
Medium
Severity
Medium
Justification
Affects 300+ securities listed on NSE; RTCM is an active surveillance tool that can result in trade cancellations for reversal patterns, directly impacting traders and brokers dealing in these stocks. High importance due to the large number of securities covered; medium impact as it targets a specific trading behaviour rather than broad market restrictions.
KRM Ayurveda Limited's equity shares to be listed on NSE EMERGE SME Platform with effect from January 29, 2026, with initial trading in Trade for Trade Surveillance Segment.
Impact
Low
Severity
Medium
Justification
Standard SME IPO listing with limited market-wide impact, relevant primarily to SME segment participants and the specific company